In conclusion, the current data suggested that LINC00680 might serve as a therapeutic target in ESCC, and ASO targeting LINC00680 represents a promising avenue for the treatment of ESCC patients. The gene discussed is LINC00680; the disease is esophageal squamous cell carcinoma.